Systematic Financial Management LP Grows Position in Enhabit, Inc. (NYSE:EHAB)

Systematic Financial Management LP grew its stake in shares of Enhabit, Inc. (NYSE:EHAB) by 12.2% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 1,838,199 shares of the company’s stock after purchasing an additional 199,235 shares during the quarter. Systematic Financial Management LP owned approximately 3.66% of Enhabit worth $14,522,000 at the end of the most recent quarter.

A number of other institutional investors have also recently made changes to their positions in EHAB. Marshall Wace LLP purchased a new stake in shares of Enhabit during the second quarter valued at approximately $1,941,000. DekaBank Deutsche Girozentrale boosted its stake in shares of Enhabit by 52.3% during the second quarter. DekaBank Deutsche Girozentrale now owns 518,412 shares of the company’s stock valued at $4,306,000 after purchasing an additional 178,000 shares during the period. Bardin Hill Management Partners LP boosted its stake in shares of Enhabit by 927.4% during the third quarter. Bardin Hill Management Partners LP now owns 174,304 shares of the company’s stock valued at $1,377,000 after purchasing an additional 157,338 shares during the period. West Tower Group LLC boosted its stake in shares of Enhabit by 108.8% during the third quarter. West Tower Group LLC now owns 285,142 shares of the company’s stock valued at $2,253,000 after purchasing an additional 148,566 shares during the period. Finally, WINTON GROUP Ltd purchased a new stake in Enhabit in the second quarter worth $955,000.

Analyst Ratings Changes

Separately, Leerink Partners reaffirmed a “market perform” rating and issued a $8.00 price target (down previously from $8.50) on shares of Enhabit in a research note on Tuesday, November 19th. One equities research analyst has rated the stock with a sell rating and six have assigned a hold rating to the stock. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $9.25.

Enhabit Price Performance

NYSE EHAB opened at $7.99 on Friday. Enhabit, Inc. has a one year low of $6.85 and a one year high of $11.74. The stock has a 50-day moving average of $7.46 and a 200 day moving average of $8.34. The company has a market capitalization of $401.52 million, a price-to-earnings ratio of -3.44 and a beta of 1.89. The company has a debt-to-equity ratio of 0.85, a quick ratio of 1.46 and a current ratio of 1.46.

Enhabit (NYSE:EHAB) last released its quarterly earnings results on Wednesday, November 6th. The company reported $0.03 EPS for the quarter, missing the consensus estimate of $0.04 by ($0.01). Enhabit had a negative net margin of 11.24% and a positive return on equity of 1.67%. The business had revenue of $253.60 million for the quarter, compared to analysts’ expectations of $261.69 million. During the same period in the previous year, the company earned $0.03 EPS. On average, sell-side analysts forecast that Enhabit, Inc. will post 0.22 EPS for the current year.

Enhabit Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.